Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

Abstract

UNLABELLED: It is unclear whether practice-related aspects of antimicrobial therapy contribute to the high mortality from septic shock among patients with cirrhosis. We examined the relationship between aspects of initial empiric antimicrobial therapy and mortality in patients with cirrhosis and septic shock. This was a nested cohort study within a large retrospective database of septic shock from 28 medical centers in Canada, the United States, and Saudi Arabia by the Cooperative Antimicrobial Therapy of Septic Shock Database Research Group between 1996 and 2008. We examined the impact of initial empiric antimicrobial therapeutic variables on the hospital mortality of patients with cirrhosis and septic shock. Among 635 patients with cirrhosis and septic shock, the hospital mortality was 75.6%. Inappropriate initial empiric antimicrobial therapy was administered in 155 (24.4%) patients. The median time to appropriate antimicrobial administration was 7.3 hours (interquartile range, 3.2-18.3 hours). The use of inappropriate initial antimicrobials was associated with increased mortality (adjusted odds ratio [aOR], 9.5; 95% confidence interval [CI], 4.3-20.7], as was the delay in appropriate antimicrobials (aOR for each 1 hour increase, 1.1; 95% CI, 1.1-1.2). Among patients with eligible bacterial septic shock, a single rather than two or more appropriate antimicrobials was used in 226 (72.9%) patients and was also associated with higher mortality (aOR, 1.8; 95% CI, 1.0-3.3). These findings were consistent across various clinically relevant subgroups. CONCLUSION: In patients with cirrhosis and septic shock, inappropriate and delayed appropriate initial empiric antimicrobial therapy is associated with increased mortality. Monotherapy of bacterial septic shock is also associated with increased mortality. The process of selection and implementation of empiric antimicrobial therapy in this high-risk group should be restructured.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 38

1. 1.

   World Health Organization. Global burden of disease.

   Not in our library

2. 2.

   Centers for Disease Control and Prevention. Chronic liver disease or cirrhosis.

   Not in our library

3. 3.

   American Liver Foundation. Liver life challenge.

   Not in our library

4. 4.

   Centers for Disease Control and Prevention.

   Not in our library

5. 5.

   Arabi Y, Ahmed QA, Haddad S, Aljumah A, Al-Shimemeri A. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol. 2004;16:333-339.

   Not in our library10.1097/00042737-200403000-00014

6. 6.

   Filloux B, Chagneau-Derrode C, Ragot S, Voultoury J, Beauchant M, Silvain C, et al. Short-term and long-term vital outcomes of cirrhotic patients admitted to an intensive care unit. Eur J Gastroenterol Hepatol. 2010;22:1474-1480.

   Not in our library10.1097/meg.0b013e32834059cd

7. 7.

   Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care. 2011;17:165-169.

   Not in our library10.1097/mcc.0b013e328344b42d

8. 8.

   Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003;124:1016-1020.

   Not in our library10.1378/chest.124.3.1016

9. 9.

   Cheruvattath R, Balan V. Infections in patients with end-stage liver disease. J Clin Gastroenterol. 2007;41:403-411.

   Not in our library10.1097/01.mcg.0000248018.08515.f9

10. 10.

    Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001;33:41-48.

    Not in our library10.1016/s1590-8658(01)80134-1

11. 11.

    Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al. Sepsis in cirrhosis: report on the 7th Meeting of the International Ascites Club. Gut. 2005;54:718-725.

    Not in our library10.1136/gut.2004.038679

12. 12.

    Navasa M, Fernandez J, Rodes J. Bacterial infections in liver cirrhosis. Ital J Gastroenterol Hepatol. 1999;31:616-625.

    Not in our library

13. 13.

    Karvellas CJ, Pink F, McPhail M, Austin M, Auzinger G, Bernal W, et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2010;38:121-126.

    Not in our library10.1097/ccm.0b013e3181b42a1c

14. 14.

    Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.

    Not in our library10.1056/nejm199908053410603

15. 15.

    Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.

    Not in our library10.1056/nejm200103083441001

16. 16.

    Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.

    Not in our library10.1056/nejmoa010307

17. 17.

    Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.

    Not in our library10.1056/nejmoa0810625

18. 18.

    Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care. 2008;14:189-197.

    Not in our library10.1097/mcc.0b013e3282f6a435

19. 19.

    Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. HEPATOLOGY. 2009;50:2022-2033.

    Not in our library10.1002/hep.23264

20. 20.

    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.

    Not in our library10.1097/01.ccm.0000298158.12101.41

21. 21.

    Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-1596.

    Not in our library10.1097/01.ccm.0000217961.75225.e9

22. 22.

    Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136:1237-1248.

    Not in our library10.1378/chest.09-0087

23. 23.

    Kumar A, Zarychanski R, Light B, Parrillo J, Maki D, Simon D, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38:1773-1785.

    Not in our library10.1097/ccm.0b013e3181eb3ccd

24. 24.

    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.

    Not in our library

25. 25.

    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY. 2001;33:464-470.

    Not in our library10.1053/jhep.2001.22172

26. 26.

    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.

    Not in our library10.1378/chest.101.6.1644

27. 27.

    Gilbert DN, Moellering RC, Eliopoulos G. Clinical approach to initial choice of antimicrobial therapy. The Sanford Guide to Antimicrobial Therapy. 2004;2-45.

    Not in our library

28. 28.

    Haukoos JS, Newgard CD. Advanced statistics: missing data in clinical research—part 1: an introduction and conceptual framework. Acad Emerg Med. 2007;14:662-668.

    Not in our library10.1197/j.aem.2006.11.037

29. 29.

    Ulldemolins M, Nuvials X, Palomar M, Masclans JR, Rello J. Appropriateness is critical. Crit Care Clin. 2011;27:35-51.

    Not in our library10.1016/j.ccc.2010.09.007

30. 30.
    Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis · 2006

    No notice
31. 31.

    Funk DJ, Kumar A. Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin. 2011;27:53-76.

    Not in our library10.1016/j.ccc.2010.09.008

32. 32.

    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164:637-644.

    Not in our library10.1001/archinte.164.6.637

33. 33.

    Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21:387-392.

    Not in our library10.1016/s0736-4679(01)00407-3

34. 34.

    McCormick PA, Greenslade L, Kibbler CC, Chin JK, Burroughs AK, McIntyre N. A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. HEPATOLOGY. 1997;25:833-836.

    Not in our library10.1002/hep.510250408

35. 35.

    Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269-282.

    Not in our library10.1007/s12072-008-9106-x

36. 36.

    Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. HEPATOLOGY. 2000;32:734-739.

    Not in our library10.1053/jhep.2000.17687

37. 37.

    Connors AF. Pitfalls in estimating the effect of interventions in the critically ill using observational study designs. Crit Care Med. 2001;29:1283-1284.

    Not in our library10.1097/00003246-200106000-00044

38. 38.

    Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care—associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791-797.

    Not in our library10.7326/0003-4819-137-10-200211190-00007

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.